肝病

订阅

MedSci主页 / 所有栏目 / 肝病

那些具有肝损害的药物汇总 ！

2016-08-01 佚名 医学之声

肝损害药物
关注

下面列举了临床常用具有肝损害的药物。以供参考！

下面列举了临床常用具有肝损害的药物。以供参考！







版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=95405, encodeId=88259540508, content=绝对实用，收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Mon Aug 01 19:25:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635739, encodeId=c8741635e393c, content=<a href='/topic/show?id=b7128123013' target=_blank style='color:#2F92EE;'>#肝损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81230, encryptionId=b7128123013, topicName=肝损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a32e22523419, createdName=ms9476844295372110, createdTime=Wed Mar 22 04:16:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95774, encodeId=b55295e7485, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Aug 03 18:55:00 CST 2016, time=2016-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95470, encodeId=c835954e049, content=实用内容，mark一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Mon Aug 01 22:18:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95441, encodeId=ae50954417a, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zGdN1x8J6HqtUI2Gpibk3sfIIBhZchAhjoiaCQlficdtQTnEqYncy3GVEMPIOJwD7t0mO2KfYGMgkIg/0, createdBy=86081727811, createdName=4546wk, createdTime=Mon Aug 01 20:30:00 CST 2016, time=2016-08-01, status=1, ipAttribution=)]
    2016-08-01 Guoxj3234

    绝对实用，收藏

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=95405, encodeId=88259540508, content=绝对实用，收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Mon Aug 01 19:25:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635739, encodeId=c8741635e393c, content=<a href='/topic/show?id=b7128123013' target=_blank style='color:#2F92EE;'>#肝损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81230, encryptionId=b7128123013, topicName=肝损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a32e22523419, createdName=ms9476844295372110, createdTime=Wed Mar 22 04:16:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95774, encodeId=b55295e7485, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Aug 03 18:55:00 CST 2016, time=2016-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95470, encodeId=c835954e049, content=实用内容，mark一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Mon Aug 01 22:18:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95441, encodeId=ae50954417a, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zGdN1x8J6HqtUI2Gpibk3sfIIBhZchAhjoiaCQlficdtQTnEqYncy3GVEMPIOJwD7t0mO2KfYGMgkIg/0, createdBy=86081727811, createdName=4546wk, createdTime=Mon Aug 01 20:30:00 CST 2016, time=2016-08-01, status=1, ipAttribution=)]
    2017-03-22 ms9476844295372110

    #肝损害#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=95405, encodeId=88259540508, content=绝对实用，收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Mon Aug 01 19:25:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635739, encodeId=c8741635e393c, content=<a href='/topic/show?id=b7128123013' target=_blank style='color:#2F92EE;'>#肝损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81230, encryptionId=b7128123013, topicName=肝损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a32e22523419, createdName=ms9476844295372110, createdTime=Wed Mar 22 04:16:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95774, encodeId=b55295e7485, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Aug 03 18:55:00 CST 2016, time=2016-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95470, encodeId=c835954e049, content=实用内容，mark一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Mon Aug 01 22:18:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95441, encodeId=ae50954417a, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zGdN1x8J6HqtUI2Gpibk3sfIIBhZchAhjoiaCQlficdtQTnEqYncy3GVEMPIOJwD7t0mO2KfYGMgkIg/0, createdBy=86081727811, createdName=4546wk, createdTime=Mon Aug 01 20:30:00 CST 2016, time=2016-08-01, status=1, ipAttribution=)]
    2016-08-03 忠诚向上

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=95405, encodeId=88259540508, content=绝对实用，收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Mon Aug 01 19:25:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635739, encodeId=c8741635e393c, content=<a href='/topic/show?id=b7128123013' target=_blank style='color:#2F92EE;'>#肝损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81230, encryptionId=b7128123013, topicName=肝损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a32e22523419, createdName=ms9476844295372110, createdTime=Wed Mar 22 04:16:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95774, encodeId=b55295e7485, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Aug 03 18:55:00 CST 2016, time=2016-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95470, encodeId=c835954e049, content=实用内容，mark一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Mon Aug 01 22:18:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95441, encodeId=ae50954417a, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zGdN1x8J6HqtUI2Gpibk3sfIIBhZchAhjoiaCQlficdtQTnEqYncy3GVEMPIOJwD7t0mO2KfYGMgkIg/0, createdBy=86081727811, createdName=4546wk, createdTime=Mon Aug 01 20:30:00 CST 2016, time=2016-08-01, status=1, ipAttribution=)]
    2016-08-01 小青虫

    实用内容，mark一下

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=95405, encodeId=88259540508, content=绝对实用，收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151005/IMG5612955936CFA7964.jpg, createdBy=18621654109, createdName=Guoxj3234, createdTime=Mon Aug 01 19:25:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1635739, encodeId=c8741635e393c, content=<a href='/topic/show?id=b7128123013' target=_blank style='color:#2F92EE;'>#肝损害#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81230, encryptionId=b7128123013, topicName=肝损害)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a32e22523419, createdName=ms9476844295372110, createdTime=Wed Mar 22 04:16:00 CST 2017, time=2017-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95774, encodeId=b55295e7485, content=好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Wed Aug 03 18:55:00 CST 2016, time=2016-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95470, encodeId=c835954e049, content=实用内容，mark一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160803/IMG57A185CE577478201.jpg, createdBy=bad41730551, createdName=小青虫, createdTime=Mon Aug 01 22:18:00 CST 2016, time=2016-08-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=95441, encodeId=ae50954417a, content=值得研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zGdN1x8J6HqtUI2Gpibk3sfIIBhZchAhjoiaCQlficdtQTnEqYncy3GVEMPIOJwD7t0mO2KfYGMgkIg/0, createdBy=86081727811, createdName=4546wk, createdTime=Mon Aug 01 20:30:00 CST 2016, time=2016-08-01, status=1, ipAttribution=)]
    2016-08-01 4546wk

    值得研究

    0

相关资讯

保健品致药物性肝损害1例报道

　　病史摘要 　　患者为女性，46岁。因“反复肝功能异常1年”入院。 　　患者1年前体检发现肝功异常，γ-谷氨酰转移酶（γ-GT）为90 U/L， 丙氨酸氨基转移酶（ALT ）为37 U/L，天冬氨酸氨基转移酶（AST）为35 U/L，碱性磷酸酶（ALP）为98 U/L ，总蛋白 

CFDA全新药物警戒：替莫唑胺的肝损害风险

2014年5月7日，加拿大卫生部（Health Canada）向医疗保健专业人员发布信息，警示替莫唑胺的肝损害风险。替莫唑胺是一种抗肿瘤药物，用于联合放射治疗新诊断的成人多形性成胶质细胞瘤，并可维持用药；也可用于治疗有证据证明经标准治疗后复发或出现疾病进展的多形性成胶质细胞瘤或间变型星形细胞瘤的成年患者。从1994年1月19日替莫唑胺上市到2013年3月15日，共收到44例接受替莫唑胺治疗后确认为

药监局：关注苯溴马隆的肝损害风险

苯溴马隆临床上主要用于原发性和继发性高尿酸血症、各种原因引起的痛风以及痛风性关节炎非急性发作期的治疗，目前主要在德国和日本、新加坡等一些亚洲国家使用。国家药品不良反应监测数据库分析显示，苯溴马隆的严重不良反应中肝损害问题比较突出。根据国内药品不良反应监测及国外监管措施情况，食品药品监管总局组织开展了苯溴马隆的风险效益评估，认为苯溴马隆在我国治疗痛风或高尿酸血症的获益仍大于风险。 国家食品药

食品药品监管总局提醒关注苯溴马隆的肝损害风险

苯溴马隆临床上主要用于原发性和继发性高尿酸血症、各种原因引起的痛风以及痛风性关节炎非急性发作期的治疗，目前主要在德国和日本、新加坡等一些亚洲国家使用。国家药品不良反应监测数据库分析显示，苯溴马隆的严重不良反应中肝损害问题比较突出。根据国内药品不良反应监测及国外监管措施情况，食品药品监管总局组织开展了苯溴马隆的风险效益评估，认为苯溴马隆在我国治疗痛风或高尿酸血症的获益仍大于风险。 国家食品药品监督

肝损害及乙型肝炎再活动1例

　　病历摘要 　　现病史 患者女性，57岁，因胃脘不适3个月、乏力1个月于2011年8月11日就诊。患者20余年前感染乙型肝炎病毒（HBV），定期到我院随访。近10年来多次随访，肝功能均正常，HBV DNA< 500拷贝/毫升，HBsAg（+），HBeAg（-），HBeAb（+）。诊断为非活动性HBsAg携带者。 　　2011年3月患者在家不慎滑倒致